Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Authors
Keywords
Myelodysplastic syndromes (MDS), RCUD, RARS, WHO classification, R-IPSS
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue 4, Pages 565-573
Publisher
Springer Nature
Online
2014-11-15
DOI
10.1007/s00277-014-2252-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management
- (2014) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes
- (2013) L. Senent et al. HAEMATOLOGICA
- Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
- (2013) J Broséus et al. LEUKEMIA
- Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification
- (2012) P. Font et al. ANNALS OF HEMATOLOGY
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts
- (2012) M. M. Patnaik et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
- (2012) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
- (2012) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
- (2012) Arjan A. van de Loosdrecht et al. LEUKEMIA & LYMPHOMA
- Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course
- (2012) Ulrike Bacher et al. LEUKEMIA RESEARCH
- Prognostic scoring systems in MDS
- (2012) Ulrich Germing et al. LEUKEMIA RESEARCH
- Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts
- (2012) Anna Maassen et al. LEUKEMIA RESEARCH
- Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers
- (2011) K. Naqvi et al. BLOOD
- Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome
- (2011) Jose Ramon Gonzalez-Porras et al. CANCER
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started